XTX Topco’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Sell |
132,937
-342,444
| -72% | -$753K | 0.01% | 1452 |
|
|
2025
Q1 | $551K | Buy |
475,381
+370,325
| +353% | +$430K | 0.03% | 956 |
|
|
2024
Q4 | $133K | Buy |
105,056
+52,498
| +100% | +$66.7K | 0.01% | 1694 |
|
|
2024
Q3 | $179K | Buy |
+52,558
| New | +$179K | 0.01% | 1476 |
|
|
2024
Q2 | – | Sell |
-21,698
| Closed | -$161K | – | 2012 |
|
|
2024
Q1 | $161K | Sell |
21,698
-7,306
| -25% | -$54.2K | 0.02% | 1242 |
|
|
2023
Q4 | $294K | Sell |
29,004
-9,778
| -25% | -$99.1K | 0.06% | 638 |
|
|
2023
Q3 | $303K | Sell |
38,782
-19,532
| -33% | -$152K | 0.05% | 725 |
|
|
2023
Q2 | $480K | Buy |
+58,314
| New | +$480K | 0.09% | 396 |
|
|
2023
Q1 | – | Sell |
-33,978
| Closed | -$301K | – | 1377 |
|
|
2022
Q4 | $301K | Buy |
33,978
+22,070
| +185% | +$196K | 0.06% | 577 |
|
|
2022
Q3 | $146K | Buy |
+11,908
| New | +$146K | 0.04% | 870 |
|
|
2021
Q2 | – | Sell |
-14,126
| Closed | -$593K | – | 872 |
|
|
2021
Q1 | $593K | Buy |
+14,126
| New | +$593K | 0.29% | 56 |
|